Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1
Satomi Kori(Yokohama City University), Kyohei Arita(Yokohama City University), Kosuke Yamaguchi(Centre National de la Recherche Scientifique), Satoru Nagatoishi(Tokyo Medical University), Makoto Nakanishi(The Cancer Institute Hospital), Pierre‐Antoine Defossez(Centre National de la Recherche Scientifique), Toru Ekimoto(Life Science Institute), Mitsunori Ikeguchi(Life Science Institute), Sae Yoshimi(Yokohama City University), Kouhei Tsumoto(Tokyo Medical University), Masateru Ohta(RIKEN Center for Computational Science), Atsuya Nishiyama(The University of Tokyo), Yuki Shibahashi(Life Science Institute)
Cited by 23
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436